GSK’s blood cancer drug Blenrep failed the main goal of a late-stage study designed to show it was better than an existing treatment on the market, the company said on Monday. Oncology is a key area of focus for GSK as a standalone prescription medicine and vaccine business and its shares fell 3 percent after…
Scientists Find Antibodies That Neutralize All COVID Strains
Previous monoclonal antibody treatments against COVID-19 have had mixed results against variants. However, new research uncovered two antibodies that work against all known strains of COVID-19. STORY AT-A-GLANCE Two antibodies have been uncovered that are so effective at neutralizing COVID-19 — and all of its variants — that they believe the antibodies could serve as…
New Science Shows Vaccines Help Omicron Spread: Peer Reviewed Study
A team of 19 scientists from the United Kingdom have published new research that helps explain why countries with the highest vaccination rates are experiencing the highest numbers of what they call “breakthrough infections,” as well as reinfection with other variants of COVID-19. This research article, published on June 14, 2022 in the peer-reviewed journal…
IgA Antibodies Appear to Protect Unvaccinated Against COVID-19: Study
March 29, 2022
admin
antibodyBrightCCP VirusCOVID-19EuropehealthHealth NewsNews & DiscoveriesPUBLIC HEALTH INFORMATIONWorld
0 Comment
Findings from a study in Sweden provide one possible explanation for why some health care workers who were in contact with COVID-19 patients every day remain uninfected, even though they were not vaccinated against the disease. “The reason why some of the staff did not contract the disease seems to have been that IgA (immunoglobulin…
Lab Tests: Eli Lilly, Regeneron Antibody Therapies Lose out Against Omicron
FRANKFURT, GERMANY—German researchers have found that COVID-19 therapies developed by Eli Lilly and Regeneron lose most of their effectiveness when exposed in laboratory tests to the Omicron variant of coronavirus, likely reducing treatment options if the new variant prevails. Two groups of Germany based scientists separately found that protection from GlaxoSmithKline and Vir’s antibody cocktail…
New Studies Suggest People Who Have Recovered From COVID-19 Should Still Get One Vaccine Dose
October 4, 2021
admin
AMERICAantibodyCCP VirusCOVID-19natural immunityPfizer BioNTechPUBLIC HEALTH INFORMATIONUSUS NewsvaccinationVaccines & Safety
0 Comment
New research from the University of California San Francisco (UCSF) and University of Minnesota (UMN) suggest that individuals who have recovered from COVID-19 should still receive one vaccination shot. The research from UCSF was published on Sept. 25. Scientists evaluated the humoral and cell-mediated response elicited by the Pfizer-BioNTech vaccine in individuals who had contracted COVID-19 and those who…
Professor of Medicine Says Data Does Not Show Occurrence of Antibody-Dependant Enhancement
News Analysis Real-world data is not showing antibody-dependent enhancement of disease occurring in COVID-19 vaccinated populations, Dr. Jay Bhattacharya said in an interview on The Sharyl Attkisson Podcast on Sunday. Antibody-dependent enhancement (ADE), also known as vaccine-enhanced disease, occurs when certain antibodies produced by a vaccine don’t protect an individual from infection but enhances viral…
UK-wide Antibody Testing Programme to Be Launched for COVID-19-Positive People
A UK-wide antibody testing programme is to be launched for people who have contracted coronavirus, the government has announced. The programme, which will offer tests to thousands of adults per day, aims to improve understanding and gain “vital” data about antibody protection following COVID-19 infection and vaccination. From Tuesday, anyone over 18 from any of…
NTD Evening News Full Broadcast (Aug. 20)
Evacuation efforts have flown 13,000 Americans and Afghans out of Afghanistan since last week, people trying to evacuate must escape both the Taliban and the shooting that takes place right outside the airport, and a monoclonal antibody treatment for COVID-19 is gaining traction in Florida.
BioNTech COVID-19 Vaccine Produces 10 Times More Antibodies Than China’s Sinovac: Study
July 18, 2021
admin
antibodyBioNTechbooster shotCCP VirusChinaChinese RegimeHong KongPfizer BioNTechSinovacVaccines & Safety
0 Comment
A new study by researchers in Hong Kong has found that recipients of BioNTech’s Comirnaty COVID-19 vaccine generate 10 times more antibodies than the Chinese CoronaVac vaccine made by Sinovac. The study reported that even after receiving their first BioNTech dose, recipients’ antibody levels were higher than those who had received two doses of Sinovac. The…
-
Recent Posts
-
Archives
- May 2025
- April 2025
- July 2023
- June 2023
- May 2023
- April 2023
- March 2023
- February 2023
- January 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- December 2021
- November 2021
- October 2021
- September 2021
- August 2021
- July 2021
- June 2021
- May 2021
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- September 2013
- July 2013
- March 2013
- January 2013
- December 2012
- November 2012
- December 1
-
Meta